₁₅Hiroshi Yanagawa

Summary for 2004 [at-glance overview of Hiroshi Yanagawa work for the selected year as suggested by data mining algorithms]

This is an Authoratory overview of author Hiroshi Yanagawa. According to available data, in 2004 Hiroshi Yanagawa published at least 15 articles. This work was completed in collaboration with several authors including Nakamura, Yoshikazu and Doi, Nobuhide. Many other authors have collaborated with Hiroshi Yanagawa as well. There is no information about the funding or the grants awarded to support this work.

Hiroshi Yanagawa is a key opinion leader on Mucocutaneous Lymph Node Syndrome, Protein Interaction Mapping. This author's highest rank is 2 when compared to all other authors using the keyword Mucocutaneous Lymph Node Syndrome. Analysis of the article abstracts and the titles suggests that Hiroshi Yanagawa professional interests are focused around "secondary structure units", "public health officers" and "government office buildings". These might also be referred to as "kawasaki disease", "rnase hi" or "smoking control". Statistical analysis shows that Hiroshi Yanagawa's writing is likely to contains terms "rnase", "disease", "kawasaki", "activity", "patients" and "vitro".

The affiliation of Hiroshi Yanagawa is uncertain, but might be related to Department of Biosciences and Informatics, Faculty of Science and Technology, Keio University, 3-14-1, Hiyoshi, Kohoku-ku, Yokohama, 223-8522, Japan. Luckily, several email addresses are on file.

EN FR ES RU

Inaccurate information, needs improvement

make correction leave comment ask question

Images [images we found on the Internet for Hiroshi Yanagawa]

Do you know Hiroshi Yanagawa who matches the profile above? Click the photo and let us know!

Alternative names (1) [other authors with names similar to Hiroshi Yanagawa]

₄₅Yanagawa, H

Year 2004 Charts [Hiroshi Yanagawa frequent coauthors and the most common unique vocabulary terms for the selected year]

Historical Performance Charts [graphical overview of Hiroshi Yanagawa publication and funding history for the range of years]

Emails (8) [email addresses extracted from Hiroshi Yanagawa affiliations]

hidden to prevent spam, click here to reveal

Hiroshi Yanagawa Coauthors (41) [all coauthors with the number of joint publications]

explore visually

3

₁₀Nakamura, Yoshikazu

3

3

2

2

2

2

2

2

2

2

2

2

2

₂Miyamoto-Sato, Etsuko

2

₂Sugahara, Yoko

2

₂Tsuji, Toru

1

₄₉Nakamura, Yusuke

1

₇Fukushima, Yoshimitsu

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

₂Higashinakagawa, Toru

1

1

1

1

1

1

1

1

Other [context-specific ads]

Affiliations (7) [condensed summary of the Hiroshi Yanagawa affiliations, the leading number and the color conveys importance]

₃Department of Biosciences and Informatics, Faculty of Science and Technology, Keio University, 3-14-1, Hiyoshi, Kohoku-ku, Yokohama, 223-8522, Japan.
₂Department of Public Health, Jichi Medical School, Tochigi, Minamikawachi, Japan.
₂Department of Pediatrics, Kurume University School of Medicine, 67 Asahi-machi, Kurume 830-0011, Japan.
₂Institute for Advanced Biosciences, Keio University, Tsuruoka, Yamagata 997-0017, Japan.
₂Department of Biosciences and Informatics, Keio University, 3-14-1 Hiyoshi, Kohoku-ku, Yokohama 223-8522. 223-8522, Japan.
₁Laboratory for Gastrointestinal Diseases, SNP Research Center, RIKEN, 1-7-22 Suehiro, Tsurumi, Yokohama, Japan.
₁Saitama Prefectural University, School of Health and Social Services.

Key Opinion Leader In [Hiroshi Yanagawa is considered a key opinion leader in any keyword where the rank of 5 is achieved, the leading number before the keyword shows the author's rank as compared to all other authors]

₂Mucocutaneous Lymph Node Syndrome | ₅Protein Interaction Mapping | ₂₉₆Japan | ₃₅₈Infant | ₅₀₄Child, Preschool | ₆₇₁Amino Acid Sequence | ₈₃₈Mutation

Keywords (32) [keywords assigned to Hiroshi Yanagawa articles by PubMed, the leading number and the color conveys importance]

₇Humans | ₅Mucocutaneous Lymph Node Syndrome | ₄Japan | ₄Child, Preschool | ₄Infant | ₄Amino Acid Sequence | ₄Female | ₄Male | ₃Child | ₃Molecular Sequence Data | ₃Mutation | ₃Protein Interaction Mapping | ₂Directed Molecular Evolution | ₂Puromycin | ₂Ribonuclease H | ₂RNA, Messenger | ₂Recombinant Fusion Proteins | ₂Escherichia coli | ₂Transcription, Genetic | ₂Case-Control Studies | ₂Genetic Complementation Test | ₂Animals | ₂Protein Binding | ₂DNA | ₂Polymerase Chain Reaction | ₂Immunoglobulins, Intravenous | ₂Cloning, Molecular | ₂Protein Folding | ₂Gene Library | ₁Mutagenesis, Site-Directed | ₁Mutagenesis | ₁Base Sequence

Hiroshi Yanagawa Unique Vocabulary (96) [single words, word pairs and phrases obtained by analysis of abstracts and titles, the leading number and the color conveys importance; Hiroshi Yanagawa might be a good expert witness on these terms]

₃₈rnase | ₂₇disease | ₂₄kawasaki | ₂₁activity | ₁₉patients | ₁₉vitro | ₁₆group | ₁₆smoking | ₁₃hi | ₁₂gene | ₁₂control | ₁₂older | ₁₁rna | ₁₀selection | ₁₀results | ₁₀mutants | ₁₀structure | ₁₀dna | ₁₀barnase | ₁₀restriction | ₁₀display | ₉proteins | ₉secondary | ₉protein | ₉type | ₈sequelae | ₈archaeal | ₈kd | ₇vs | ₇programs | ₇using | ₆significantly
₂₄kawasaki disease | ₁₃rnase hi | ₁₁smoking control | ₁₁rnase activity | ₉secondary structure | ₈type rnase | ₇public health | ₇structure units | ₆older group | ₆health officers | ₆barnase mutants | ₅control programs | ₅younger group | ₅government office | ₅office buildings | ₅archaeal type | ₅vitro selection | ₅risk factor | ₅intravenous gamma-globulin | ₄group vs | ₄control measures | ₄additional ivgg | ₄cardiac sequelae | ₄nationwide surveys | ₄whose parents | ₄dsrnase activity | ₄mrna display | ₄restriction endonucleases | ₄cardiovascular sequelae | ₄local municipalities | ₄restriction enzymes | ₃group significantly
₇secondary structure units | ₆public health officers | ₅government office buildings | ₅smoking control programs | ₅archaeal type rnase | ₄younger group vs | ₄smoking control measures | ₃kawasaki disease whose | ₃barnase mutants obtained | ₃type rnase gene | ₃risk factor cardiovascular | ₃tokodaii rnase hi | ₃patients kawasaki disease | ₃age risk factor | ₃vitro selection restriction | ₃mutants obtained permutation | ₂jun-associated proteins using | ₂administration intravenous immunoglobulin | ₂display biologically active | ₂development cardiovascular sequelae | ₂rnase hi can | ₂gene kawasaki disease | ₂hi can cleave | ₂nrc-1 archaeal rnase | ₂proteins vitro protein | ₂biologically active proteins | ₂cleave rna-dna junction | ₂vitro protein selection | ₂ligand gene kawasaki | ₂vitro selection jun-associated | ₂archaeal rnase hi | ₂treated intravenous gamma-globulin

Reader's Comments (0) [comments posted by readers of Hiroshi Yanagawa profile]